Impact of antiretroviral treatment on gene expression in peripheral blood mononuclear cells from SIVmac251-infected macaques

Journal of Infectious Diseases

Volumn 196, Issue 3, 2007, Pages 384-393

  Vahey, Maryanne T ^a,d   Ockenhouse, Christian F ^a   Wang, Zhining ^b   Yalley Ogunro, Jake ^c   Greenhouse, Jack ^c   Nau, Martin E ^b   Lewis, Mark G ^c  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c BIOQUAL INC   (United States)

^d US Military HIV Research Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE; TENOFOVIR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; INFLAMMATION; MACACA; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RNA VIRUS INFECTION; SEROCONVERSION; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; ANTIVIRAL AGENTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LEUKOCYTES, MONONUCLEAR; MACACA FASCICULARIS; PHYLOGENY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TIME FACTORS; VIRAL LOAD;

EID: 34447628190     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/519388     Document Type: Article

References (44)

1. Reimann KA, Parker RA, Seaman M, et al. Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques associated with early T lymphocyte responses. J Virol 2005; 79:8878-85.
2. Monceaux V, Viollet, L, Petit F, et al. CD8+ T cell dynamics during primary simian immunodeficiency virus infection in macaques: relationship of effector cell differentiation with the extent of viral replication. J Immunol 2005; 174:6898-908.
3. +-T-cell profiles during the asymptomatic phase of simian immunodeficiency virus SIVmac251 infection in rhesus macaques. J Virol 2003; 77:10047-59.
4. Mattapallil JJ, Letvin NL, Roederer M. T cell dynamics during acute SIV infection. AIDS 2004; 18:13-23.
5. Homann D, Teyton L, Oldstone BA. Differential regulation of antiviral T cell immunity results in stable CD8+ but declining CD4+ T cell memory. Nat Med 2001; 7:913-9.
6. Straprans SI, Dailey PJ, Rosenthal A, et al. Simian immunodeficiency virus disease course is predicted by the extent of virus replication during primary infection. J Virol 1999; 73:4829-39.
7. Mellors JW, Rinaldo CR, Gupta RM, White JA, Kingsley LA. Prognosis of HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272:1167-70.
8. Lifson JD, Nowak MA, Goldstein S, et al. The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection. J Virol 1997; 71:9508-14.
9. Watson A, Ranchalis J, Travis B, et al. Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival. J Virol 1997; 71:284-90.
10. Letvin NL, Mascola JR, Sun Y, et al. Preserved CD4+ central memory T cells and survival in vaccinated SIV challenged monkeys. Science 2006; 312:1530-3.
11. + T lymphocytes in vaccinated, simian immunodeficiency virus infected rhesus monkeys. J Immunol 2006; 176: 5338-45.
12. Haaft PT, Veerstrepen B, Uberla K, Rosenwirth B, Heenly J. A pathogenic threshold of virus load defined in simian immunodeficiency virus or simian human immunodeficiency virus infected macaques. J Virol 1998; 72:10281-5.
13. Estaquier J, Idziorek T, De Bels F. Programmed cell death and AIDS: significance of T cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci USA 1994; 91:9431-5.
14. Estaquier J, Monceaux V, Cumont MC, Aubertin AM, Hurtrel B, Ameisen JC. Early changes in peripheral blood T cells during primary infection of rhesus macaques with a pathogenic SIV. J Med Primatol 2000; 29:127-35.
15. Arnoult D, Petit F, Lelievie JD. Caspase-dependent and -independent T-cell death pathways in pathogenic simian immunodeficiency virus infection: relationship to disease progression. Cell Death Differ 2003; 10: 1240-52.
16. Hel Z, Nacs J, Kelsall B. Impairment of gag specific CD8+ T cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251 and simian-human immunodeficiency virus KU2 infected macaques. J Virol 2001; 75:11483-95.
17. + lymphocyte response in acutely infected rhesus macaques. J Virol 1993; 67:1707-11.
18. Régulier EG, Panemangalore R, Richardson MW, et al. Persistent antigag -Nef and -Rev IgM levels as markers of the impaired functions of CD4+ T helper lymphocytes during SIVmac251 infection of cynomolgus macaques. J Acquir Immune Defic Syndr 2005; 40:1-11.
19. Kaur A, Halle CL, Ramanujan S, Jain RK, Johnson RP. Differential dynamics of CD4+ and CD8+ T lymphocyte proliferation and activation in acute simian immunodeficiency virus infection. J Virol 2000; 74:8413-24.
20. Schmitz JE, Kuroda MJ, Santra S. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999; 283:857-60.
21. Lifson JD, Rossio JL, Arnaout R. Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient post inoculation antiretroviral treatment. J Virol 2000; 74:2584-93.
22. Lifson JD, Piatak M, Cline AN, Rossio JL. Transient early post inoculation anti-retroviral treatment facilitates controlled infection with sparing of CD4+ T cells in gut associated lymphoid tissue in SIVmac239 infected rhesus macaques but not resistance to rechallenge, J Med Primatol 2003; 32:201-10.
23. Benlhassan-Chohour K, Penit C, Dioszeghy V. Kinetics of lymphocyte proliferation during primary immune response in macaques infected with pathogenic simian immunodeficiency virus SIVmac251: preliminary report of the effect of early antiviral therapy. J Virol 2003; 77: 12479-93.
24. Carruth LM, Zink MC, Tarwater PM. SIV specific T lymphocyte responses in PBMC and lymphoid tissues of SIV infected pigtailed macaques during suppressive combination antiretroviral therapy. J Med Primatol 2005; 34:109-21.
25. George MD, Reay E, Sankaran S, Dandekar S. Early antiretroviral therapy for simian immunodeficiency virus infection leads to mucosal CD4+ T cell restoration and enhanced gene expression regulating mucosal repair and regeneration. J Virol 2005; 79:2709-19.
26. + lymphocyte apoptosis in acutely SIV infected rhesus macaques after short term antiretroviral treatment. Virology 2001; 279:221-32.
27. Silvera P, Richardson MS, Greenhouse JJ. Outcome of simian-human immunodeficiency virus strain 89.6p challenge following vaccination of rhesus macaques with human immunodeficiency virus Tat protein. J Virol 2002; 76:3800-9.
28. Vahey MT, Nau ME, Taubman M, Yalley-Ogunro J, Silvera P, Lewis MG. Patterns of gene expression in peripheral blood mononuclear cells of rhesus macaques infected with SIVmac251 and exhibiting differential rates of disease expression. AIDS Res Hum Retrovir 2003; 19:369-87.
29. Li C, Wong W. Model based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 2001; 98:31-6.
30. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003; 31:e15.
31. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98:5116-21.
32. Dennis G Jr, Sherman BT, Hosack DA, et al. DAVID: database for annotation, visualization and integrated discovery. Genome Biol 2003; 4:P3.
33. Draghici S, Khatri P, Bhavsar P, Shah A, Krawetz S, Tainsky MA. Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate. Nucleic Acids Res 2003; 31: 3775-81.
34. Rosenwirth B, Ten Haft P, Bogers WM. Antiretroviral therapy during primary immunodeficiency virus infection can induce persistent suppression of virus load and protection from heterologous challenge in rhesus macaques. J Virol 2000; 74:1704-11.
35. Tryniszewska E, Nasca J, Lewis MG. Vaccination of macaques with long standing SIVmac251 infection lowers the viral set point after cessation of antiretroviral therapy. J Immunol 2002; 169:5347-57.
36. Van Rompay KK, Singh RP, Brignolo LL. The clinical benefits of tenofovir for simian immunodeficiency virus infected macaques are larger than predicted by its effects on standard viral and immunologic parameters. J Acquir Immune Defic Syndr 2004; 36:900-14.
37. Le Grand R, Clayette P, Noack O. An animal model for antilentiviral therapy: effect of zidovudine on viral load during acute infection after exposure of macaques to simian immunodeficiency virus. AIDS Res Hum Retrovir 1994; 10:1279-87.
38. Clerici M, Sarin AA, Coffman RL. Type 1/type 2 cytokine modulation of T cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sci USA 1994; 91:11811-5.
39. Rose JJ, Janvier K, Chandrasekhar S, Sekaly RP, Bonafacino JS, Venkatesan S. CD4 down-regulation by HIV-1 and simian immunodeficiency virus (SIV) Nef proteins involves both internalization and intracellular retention mechanisms. J. Biol Chem 2005; 280:7413-26.
40. Crawford K, Stark A, Kitchens B, et al. CD2 engagement induces dendritic cell activation: implications for immune surveillance and T cell activation. Blood 2003; 102:1745-52.
41. Gonsky R, Deem RL, Young HA, Targan SR. CD2 mediates activation of the IFN gamma intronic SAT binding region in mucosal T cells. Eur J Immunol 2003; 33:1152-62.
42. Stamenkovic I, Seed B. CD19, the earliest differentiation antigen of the B cell lineage, bears three extracellular immunoglobulin-like domains and an Epstein-Barr virus related cytoplasmic tail. J Exp Med 1988; 168:1205-10.
43. Wang Y, Brooks SR, Li X, Anzelon AN, Rickert RC, Carter RH. The physiologic role of CD19 cytoplasmic tyrosines. Immunity 2002; 17: 501-14.
44. Bouwmeester T, Bauch A, Ruffner A, et al. A physical and functional map of the human TNF alpha; NFKB1 signal transduction pathway. Nat Cell Biol 2004; 6:97-105.